• 3X FLAG Peptide for Protein Workflows

  2026-09-14

  The 3X (DYKDDDDK) Peptide adds a high-visibility, competition-ready reagent to FLAG-based detection, purification, ELISA, and crystallization workflows. Its hydrophilic triple-repeat design is especially useful when assay sensitivity, metal compatibility, or tag accessibility is limiting.

• Topotecan (SKF104864) Workflow for Cancer Research

  2026-09-14

  Topotecan combines a defined topoisomerase I mechanism with practical utility in glioma, stem-cell, and pediatric tumor workflows. This guide translates pharmacology into concentration selection, assay design, combination planning, and troubleshooting for reproducible cancer research.

• Triterpene Prodrug for Targeted OSCC Therapy

  2026-09-13

  A 2024 ACS Applied Materials & Interfaces study developed a carrier-free prodrug that combines glycyrrhetinic acid and ginsenoside Rh2 through ROS-responsive thioketal chemistry and rapid solvent-exchange assembly. The design links tumor-associated ROS to drug release and further oxidative amplification, offering a mechanistically coherent strategy for targeted oral squamous cell carcinoma chemotherapy while highlighting the remaining translational questions for natural-product nanomedicines.

• Reactive Oxygen Species Assay Kit for Superoxide

  2026-09-12

  The Reactive Oxygen Species Assay Kit (DHE) turns live-cell superoxide detection into a practical workflow for toxin, immunotoxicity, and redox studies. Applied to DON-exposed chicken macrophages, it can connect oxidative stress measurements with caspase-1, cytokine, and protective-compound experiments while preserving essential controls.

• WIP1/PPM1D, p38 MAPK, and Pyroptosis in Septic AKI

  2026-09-11

  The reference study identifies WIP1/PPM1D as a restraint on p38 MAPK-driven renal tubular pyroptosis during sepsis-associated acute kidney injury. Using single-cell data, human kidney samples, LPS injury models, and pharmacological inhibition with CCT007093, it connects elevated WIP1 with a p38-dependent inflammatory cell-death program.

• Verapamil Targets Txnip in Osteoporosis Research

  2026-09-11

  Cao et al. identify TXNIP variation as associated with osteoporosis-related bone mineral density and show that verapamil reduces ovariectomy-associated bone loss in mice. The study connects ChREBP-dependent TXNIP regulation with coordinated effects on osteoclast and osteoblast pathways, providing a preclinical rationale for investigating drug repurposing in postmenopausal osteoporosis.

• Antimycins as ATP-Citrate Lyase Inhibitors

  2026-09-10

  The reference study established that antimycin-class antibiotics from a Streptomyces species inhibit ATP-citrate lyase, connecting a historically known respiratory-chain inhibitor class with cytoplasmic acetyl-CoA production. Its fermentation, chromatographic, spectroscopic, and enzyme-assay workflow provides a useful framework for studying how antimycin congeners affect lipid precursor metabolism while recognizing their potential mitochondrial confounding activity.

• gamma-Glu-Cys (γ-Glu-Cys): Lab Protocol Guide

  2026-09-10

  This guide explains how to use gamma-Glu-Cys (γ-Glu-Cys) as a defined substrate and glutathione biosynthesis intermediate in enzyme, peptide, and plant-related workflows. It covers preparation, storage, QC, and assay controls while limiting interpretation to research use; the product is not intended for diagnostic, therapeutic, or medical applications.

• Asymmetric HflK/C Controls FtsH Proteolysis

  2026-09-09

  The reference study shows that native HflK/C does not form a uniformly closed cage around FtsH, but instead adopts an asymmetric nautilus-like assembly with an entryway for membrane proteins. Cryo-EM, proteomic degradation assays, and lipid-scrambling measurements connect this architecture to substrate access, membrane remodeling, and enhanced degradation of selected membrane-embedded proteins.

• AZD0156: Designing Smarter ATM Inhibition Assays

  2026-09-09

  AZD0156 is a selective ATM kinase inhibitor for investigating DNA damage response signaling, repair dependence, and combination effects. This guide translates ovarian cancer evidence into practical assay-design decisions for rigorous cancer therapy research.

• gamma-Glu-Cys: Designing Better Glutathione Assays

  2026-09-08

  gamma-Glu-Cys is a defined intermediate for glutathione synthetase enzyme assay development and glutathione metabolism research. This article explains how its biochemical position, matrix effects, and handling requirements can improve assay interpretation across microbial and plant systems.

• c-Myc tag Peptide for Immunoassay Workflows

  2026-09-08

  Use a defined c-Myc tag competitor to test antibody specificity, optimize tagged-protein recovery, and separate epitope effects from biological conclusions. This workflow-focused guide connects peptide displacement assays with transcription-factor research while clarifying practical limits, formulation choices, and troubleshooting steps.

• Caspase-4 Colorimetric Assay Kit: A Mechanistic Guide

  2026-09-07

  Discover how the Caspase-4 Colorimetric Assay Kit converts LEVD-dependent enzyme activity into a quantitative readout for pyroptosis and inflammation studies. This guide also explains how to interpret caspase-4 data alongside emerging organelle-targeted cancer-cell models without confusing pathway correlation with causation.

• Methylprednisolone Sodium Succinate in Cell Assays

  2026-09-07

  Build reproducible inflammation, immune-cell trafficking, and tumor-cell response assays with a water-soluble synthetic corticosteroid. This guide connects concentration-aware experimental design with practical controls, troubleshooting, and a careful comparison to receptor-pharmacology lessons from palonosetron research.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-09-05

  Use EZ Cap EGFP mRNA 5-moUTP as a bright, stable reporter for cell transfection, LNP biodistribution, translation benchmarking, and fluorescent imaging. Its Cap1 structure, 5-methoxyuridine, and optimized poly(A) tail help separate delivery performance from avoidable RNA instability and innate immune effects.

8181 records 1/546 page Next 12345 下5页 Last page